Beyond glucose lowering, GLP-1 RAsinduce satiety and promote weight loss, addressing the obesity-diabetes nexusthat exacerbates insulin resistance and complicates disease management [7, 8].Importantly, GLP-1 RAs also demonstrate reno-protective properties. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.